Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
24 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
Hyloris from Liège, company number BE0669738676, closed financial year 2025 with a result of € -100,517 after tax. For that financial year Hyloris recorded revenue of € 384,852 and equity of € 706,225. Compared with financial year 2024, the result moved from € 22,759 to € -100,517. The company made a loss. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 7, 2026.
€ 706,225
▲ € 2.4 million vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -100,517
▼ still € 22,759 profit in 2024
Profit after tax over the fiscal year.
€ 298,658
▼ 49% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -100,517.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 244,208
▲ 144% vs 2024
Supplier invoices still open on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | - | € 53,250 | - | € 384,852 | |
| Gross margin | € -4,352 | € 34,463 | € 170,697 | € 36,595 | ▼ 79% |
| Profit after taxes | € -148,510 | € -146,630 | € 22,759 | € -100,517 | ▼ € 123,276 |
| Equity | € -1,569,387 | € -1,716,017 | € -1,693,258 | € 706,225 | ▲ € 2.4 million |
| Total debts | € 2,291,801 | € 2,735,939 | € 2,689,812 | € 872,164 | ▼ 68% |
| Cash | € 690,426 | € 699,207 | € 580,519 | € 298,658 | ▼ 49% |
| Retained profit | € -1,631,387 | € -1,778,017 | € -1,755,258 | € -100,517 | ▲ € 1.7 million |
| Bank debt | € 2,101,122 | € 2,331,004 | € 0 | € 0 | |
| Balance sheet total | € 722,414 | € 1,019,922 | € 996,554 | € 1,578,389 | ▲ 58% |
Key figures of Hyloris, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Hyloris?
What happened at Hyloris in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 100,517 (▼ € 123,276 vs 2024). Source: NBB ↗
- Jacobsen Management SRL stepped down as director. NBB
- SVR Management SRL stepped down as director. NBB
- Jacobsen Management SRL became a director. NBB
- SVR Management SRL became a director. NBB
- New establishment in Liège. KBO
- Start of the company according to the CBE. KBO
In short
From € 148,510 loss in 2022 to € 100,517 loss in 2025.
Paid € 3,433 in corporate taxes since 2022.
Best year ever: 2024, with € 22,759 profit.
A new publication or filing at Hyloris? We notify you, reason included.
Follow HylorisDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of Hyloris Pharmaceuticals comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
HylorisThe shares are held by Hyloris Pharmaceuticals (100%).
Directors
According to the 2025 annual accounts
Director · represented by Thomas Jacobsen
Also active at: Hyloris Developments, DERMAX, Hyloris Pharmaceuticals
since 2020 · until 2026
Managing director · represented by Stijn Van Rompay
Also active at: Hyloris Developments, DERMAX, Hyloris Pharmaceuticals
since 2020 · until 2026
Shareholders
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Boulevard de Patience et Beaujonc 3 box 1
4000 Liège
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 24 companies are registered at this address.
All companies at this address →Hyloris Developments same network
€ 5.1 million revenue · 2025
ONCORADIOMICS
€ 2.4 million gross margin · 2025
DERMAX same network
€ 1.6 million revenue · 2025
Hyloris Pharmaceuticals same network
€ 3.8 million revenue · 2025
Hirundo Biosciences
€ 0 revenue · 2025
+19 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0669.738.676
- VAT number
- BE 0669.738.676
- Registered office
- Boulevard de Patience et Beaujonc 3 bus 1, 4000 Liège
- Names & denominations
- Hyloris
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 18 January 2017
- Peppol
- Active · Active since 21 Oct 2025
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Vervaardiging van farmaceutische grondstoffen